220 related articles for article (PubMed ID: 36016137)
1. Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing.
Mosharaf MP; Kibria MK; Hossen MB; Islam MA; Reza MS; Mahumud RA; Alam K; Gow J; Mollah MNH
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016137
[TBL] [Abstract][Full Text] [Related]
2. Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing.
Mosharaf MP; Reza MS; Kibria MK; Ahmed FF; Kabir MH; Hasan S; Mollah MNH
Sci Rep; 2022 Mar; 12(1):4279. PubMed ID: 35277538
[TBL] [Abstract][Full Text] [Related]
3. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
Islam MA; Kibria MK; Hossen MB; Reza MS; Tasmia SA; Tuly KF; Mosharof MP; Kabir SR; Kabir MH; Mollah MNH
Sci Rep; 2023 Mar; 13(1):4685. PubMed ID: 36949176
[TBL] [Abstract][Full Text] [Related]
5. Identification of host genomic biomarkers from multiple transcriptomics datasets for diagnosis and therapies of SARS-CoV-2 infections.
Sarker B; Rahaman MM; Islam MA; Alamin MH; Husain MM; Ferdousi F; Ahsan MA; Mollah MNH
PLoS One; 2023; 18(3):e0281981. PubMed ID: 36913345
[TBL] [Abstract][Full Text] [Related]
6. Integrative transcriptomics analysis of lung epithelial cells and identification of repurposable drug candidates for COVID-19.
Islam T; Rahman MR; Aydin B; Beklen H; Arga KY; Shahjaman M
Eur J Pharmacol; 2020 Nov; 887():173594. PubMed ID: 32971089
[TBL] [Abstract][Full Text] [Related]
7. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
Front Immunol; 2021; 12():789317. PubMed ID: 34975885
[TBL] [Abstract][Full Text] [Related]
8. Molecular crosstalk between COVID-19 and Alzheimer's disease using microarray and RNA-seq datasets: A system biology approach.
Premkumar T; Sajitha Lulu S
Front Med (Lausanne); 2023; 10():1151046. PubMed ID: 37359008
[TBL] [Abstract][Full Text] [Related]
9. Disclosing Potential Key Genes, Therapeutic Targets and Agents for Non-Small Cell Lung Cancer: Evidence from Integrative Bioinformatics Analysis.
Mosharaf MP; Reza MS; Gov E; Mahumud RA; Mollah MNH
Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632527
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics and systems biology analysis revealed PMID26394986-Compound-10 as potential repurposable drug against covid-19.
Nisar H; Wajid B; Anwar F; Ahmad A; Javaid A; Attique SA; Nisar W; Saeed A; Shahid S; Sadaf S
J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37534820
[TBL] [Abstract][Full Text] [Related]
11. The Biological Interaction of SARS-CoV-2 Infection and Osteoporosis: A Preliminary Study.
Kang X; Wen X; Liang J; Liu L; Zhang Y; Wang Q; Zhao H
Front Cell Dev Biol; 2022; 10():917907. PubMed ID: 35646907
[TBL] [Abstract][Full Text] [Related]
12. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
Fang KY; Cao WC; Xie TA; Lv J; Chen JX; Cao XJ; Li ZW; Deng ST; Guo XG
Hum Genomics; 2021 Mar; 15(1):18. PubMed ID: 33726831
[TBL] [Abstract][Full Text] [Related]
13. Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases.
Al-Mustanjid M; Mahmud SMH; Akter F; Rahman MS; Hossen MS; Rahman MH; Moni MA
Inform Med Unlocked; 2022; 32():101003. PubMed ID: 35818398
[TBL] [Abstract][Full Text] [Related]
14. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV.
Yan C; Niu Y; Wang X
Front Immunol; 2022; 13():1008653. PubMed ID: 36389792
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics and system biology approach to identify the influences of SARS-CoV-2 infections to idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease patients.
Mahmud SMH; Al-Mustanjid M; Akter F; Rahman MS; Ahmed K; Rahman MH; Chen W; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33847347
[TBL] [Abstract][Full Text] [Related]
16. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
Xie TA; He ZJ; Liang C; Dong HN; Zhou J; Fan SJ; Guo XG
Eur J Med Res; 2021 Dec; 26(1):146. PubMed ID: 34920753
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.
Vastrad B; Vastrad C; Tengli A
Gene Rep; 2020 Dec; 21():100956. PubMed ID: 33553808
[TBL] [Abstract][Full Text] [Related]
18. Potential Molecular Mechanisms and Remdesivir Treatment for Acute Respiratory Syndrome Corona Virus 2 Infection/COVID 19 Through RNA Sequencing and Bioinformatics Analysis.
Prashanth G; Vastrad B; Vastrad C; Kotrashetti S
Bioinform Biol Insights; 2021; 15():11779322211067365. PubMed ID: 34992355
[TBL] [Abstract][Full Text] [Related]
19. Identification of hub genes associated with COVID-19 and idiopathic pulmonary fibrosis by integrated bioinformatics analysis.
Chen Q; Xia S; Sui H; Shi X; Huang B; Wang T
PLoS One; 2022; 17(1):e0262737. PubMed ID: 35045126
[TBL] [Abstract][Full Text] [Related]
20. To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics.
Shen Q; Wang J; Zhao L
Math Biosci Eng; 2022 Aug; 19(11):11172-11194. PubMed ID: 36124586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
